Literature DB >> 4346011

Passive protection of mice against intracerebral infections with Bordetella pertussis.

J M Dolby.   

Abstract

The passive protection of mice against an intracerebral infection with Bordetella pertussis, by antiserum introduced directly into the brain with the infecting organisms, was compared with the protection afforded by intraperitoneal antiserum. The antibody effective by the intracerebral route is that which is adsorbed onto the infecting organisms, although it does not affect the viability of the organisms in vitro in the absence of complement.PASSIVE PROTECTION AGAINST ORGANISMS INTRODUCED INTRACEREBRALLY TAKES PLACE IN ONE OF TWO WAYS, DEPENDING ON THE SIZE OF THE CHALLENGE: (1) after 3-4 days' growth, the growth rate declines so that the number of organisms does not reach the figure lethal for the mouse; (2) the organisms do not appear to multiply, as their numbers decline from the moment of injection, so that the brain is sterile after 2 days.Many of the mice protected against a challenge of 50,000 organisms (ca. 100 LD 50) by intraperitoneal or intracerebral antiserum recover by the first mechanism. The second mechanism operates after a smaller challenge of 5000 organisms (ca. 10 LD 50), irrespective of whether the antiserum is given intracerebrally with the challenge, or intraperitoneally within several hours of challenge. Too much antiserum given intracerebrally with a 50,000 challenge, but not with a 5000 challenge, inhibits protection.In some mice, virulent antibody-treated organisms which have not been killed, grow very slowly over a long period, but are eventually eliminated from the brain.

Entities:  

Mesh:

Substances:

Year:  1972        PMID: 4346011      PMCID: PMC2130277          DOI: 10.1017/s0022172400022555

Source DB:  PubMed          Journal:  J Hyg (Lond)        ISSN: 0022-1724


  7 in total

1.  The intranasal infection of mice with Bordetella pertussis.

Authors:  J M DOLBY; D C THOW; A F STANDFAST
Journal:  J Hyg (Lond)       Date:  1961-06

2.  The intracerebral infection of mice with Bordetella pertussis.

Authors:  J M DOLBY; A F STANDFAST
Journal:  J Hyg (Lond)       Date:  1961-06

3.  Pertussis Vaccine Prepared with Phase-I Cultures Grown in Fluid Medium.

Authors:  S M Cohen; M W Wheeler
Journal:  Am J Public Health Nations Health       Date:  1946-04

4.  Pyrrolidonyl peptidase activity: a simple test for differentiating staphylococci.

Authors:  M Mulczyk; A Szewczuk
Journal:  J Gen Microbiol       Date:  1972-04

5.  The antibacterial effect of Bordetella pertussis antisera.

Authors:  J M Dolby
Journal:  Immunology       Date:  1965-05       Impact factor: 7.397

6.  Intracerebral mouse protection test for petussis vaccine. II. Immunosuppression with cyclophosphamide.

Authors:  H E Blake; A C Wardlaw
Journal:  Can J Microbiol       Date:  1969-12       Impact factor: 2.419

7.  The influence of the route of immunization on the protection of mice infected intracerebrally with Bordetella pertussis.

Authors:  A F Standfast; J M Dolby
Journal:  J Hyg (Lond)       Date:  1972-09
  7 in total
  2 in total

1.  The effects of humoral, cellular and non-specific immunity on intracerebral Bordetella pertussis infections in mice.

Authors:  J M Dolby; D E Dolby; C J Bronne-Shanbury
Journal:  J Hyg (Lond)       Date:  1975-02

2.  The effect of the antigen which elicits the bactericidal antibody and of the mouse-protective antigen on the growth of Bordetella pertussis in the mouse brain.

Authors:  J M Dolby; J P Ackers; D E Dolby
Journal:  J Hyg (Lond)       Date:  1975-02
  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.